共 159 条
[1]
Hachim A(2020)ORF8 and ORF3b antibodies are accurate serological markers of early and late SARS-CoV-2 infection Nat Immunol 21 1293-1301
[2]
Kavian N(2020)Disease severity dictates SARS-CoV-2-specific neutralizing antibody responses in COVID-19 Signal Transduct Target Ther 5 180-21
[3]
Cohen CA(2021)Characterization of neutralizing versus binding antibodies and memory B cells in COVID-19 recovered individuals from India Virology 558 13-399
[4]
Chin AWH(2020)Serological tests for COVID-19 Med J Aust 213 397-631
[5]
Chu DKW(2020)Antibody tests for identification of current and past infection with SARS-CoV-2 Cochrane Database Syst Rev 6 CD013652-147
[6]
Mok CKP(2020)Assessment of SARS-CoV-2 serological tests for the diagnosis of COVID-19 through the evaluation of three immunoassays: two automated immunoassays (Euroimmun and Abbott) and one rapid lateral flow immunoassay (NG Biotech) J Clin Virol 129 104511-S456
[7]
Chen X(2020)Development of epitope-based peptide vaccine against novel coronavirus 2019 (SARS-COV-2): Immunoinformatics approach J Med Virol 92 618-848
[8]
Pan Z(2020)Immunoinformatic identification of B cell and T cell epitopes in the SARS-CoV-2 proteome Sci Rep 10 14179-1734
[9]
Yue S(2018)Antigen specificity and clinical significance of IgG and IgA autoantibodies produced in situ by tumor-infiltrating B cells in breast cancer Front Immunol 9 2660-288
[10]
Yu F(2013)Tumor-associated autoantibody signature for the early detection of gastric cancer IntJCancer 132 137-308